These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 6282959

  • 1. Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels.
    Ashworth LA, Fitzgeorge RB, Irons LI, Morgan CP, Robinson A.
    J Hyg (Lond); 1982 Jun; 88(3):475-86. PubMed ID: 6282959
    [Abstract] [Full Text] [Related]

  • 2. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
    Thomas MG, Ashworth LA, Miller E, Lambert HP.
    J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651
    [Abstract] [Full Text] [Related]

  • 3. A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteers.
    Berstad AKH, Holst J, Frøholm LO, Haugen IL, Wedege E, Oftung F, Haneberg B.
    J Med Microbiol; 2000 Feb; 49(2):157-163. PubMed ID: 10670566
    [Abstract] [Full Text] [Related]

  • 4. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.
    Kimura A, Mountzouros KT, Relman DA, Falkow S, Cowell JL.
    Infect Immun; 1990 Jan; 58(1):7-16. PubMed ID: 2294058
    [Abstract] [Full Text] [Related]

  • 5. Protective activities in mice of monoclonal antibodies against pertussis toxin.
    Sato H, Sato Y.
    Infect Immun; 1990 Oct; 58(10):3369-74. PubMed ID: 1698179
    [Abstract] [Full Text] [Related]

  • 6. Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis.
    Sato Y, Izumiya K, Sato H, Cowell JL, Manclark CR.
    Infect Immun; 1981 Mar; 31(3):1223-31. PubMed ID: 6262248
    [Abstract] [Full Text] [Related]

  • 7. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA.
    Roberts M, Cropley I, Chatfield S, Dougan G.
    Vaccine; 1993 Mar; 11(8):866-72. PubMed ID: 8356847
    [Abstract] [Full Text] [Related]

  • 8. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R, Lønnes T, Møgster B, Berdal BP.
    Dev Biol Stand; 1985 Mar; 61():353-65. PubMed ID: 2872124
    [Abstract] [Full Text] [Related]

  • 9. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
    Cahill ES, O'Hagan DT, Illum L, Redhead K.
    FEMS Microbiol Lett; 1993 Mar 01; 107(2-3):211-6. PubMed ID: 8472903
    [Abstract] [Full Text] [Related]

  • 10. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children.
    Ashworth LA, Robinson A, Irons LI, Morgan CP, Isaacs D.
    Lancet; 1983 Oct 15; 2(8355):878-81. PubMed ID: 6137697
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB, Huang YY, Halperin SA, Anderson R, Morris A, Macmillan A, Jones T, Burt DS, Van Nest G, Lee SF.
    Clin Exp Immunol; 2006 Jun 15; 144(3):543-51. PubMed ID: 16734625
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of serology and nasopharyngeal cultures for diagnosis of pertussis in a vaccine efficacy trial.
    Hallander HO, Storsaeter J, Möllby R.
    J Infect Dis; 1991 May 15; 163(5):1046-54. PubMed ID: 2019753
    [Abstract] [Full Text] [Related]

  • 13. Quantification of pertussis toxin, filamentous haemagglutinin, 69 kDa outer membrane protein, agglutinogens 2 and 3 and lipopolysaccharide in the Danish whole-cell pertussis vaccine.
    Ibsen PH, Petersen JW, Heron I.
    Vaccine; 1993 May 15; 11(3):318-22. PubMed ID: 8447160
    [Abstract] [Full Text] [Related]

  • 14. Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice.
    Jabbal-Gill I, Fisher AN, Rappuoli R, Davis SS, Illum L.
    Vaccine; 1998 Dec 15; 16(20):2039-46. PubMed ID: 9796062
    [Abstract] [Full Text] [Related]

  • 15. Quantification of cell-associated and free antigens in Bordetella pertussis suspensions by antigen binding ELISA.
    Westdijk J, van den Ijssel J, Thalen M, Beuvery C, Jiskoot W.
    J Immunoassay; 1997 Aug 15; 18(3):267-84. PubMed ID: 9257265
    [Abstract] [Full Text] [Related]

  • 16. Does whole-cell pertussis vaccine protect black South African infants? Assessment of post-vaccination events and antibody responses to pertussis toxin, filamentous haemagglutinin and agglutinogens 2 and 3.
    Ramkissoon A, Coovadia HM, Loening WE, Ndlovana M.
    S Afr Med J; 1991 Jun 01; 79(11):645-9. PubMed ID: 1675492
    [Abstract] [Full Text] [Related]

  • 17. Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine.
    Petersen JW, Andersen P, Ibsen PH, Capiau C, Wachmann CH, Hasløv K, Heron I.
    Vaccine; 1993 Jun 01; 11(4):463-72. PubMed ID: 8470432
    [Abstract] [Full Text] [Related]

  • 18. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
    Macdonald-Fyall J, Xing D, Corbel M, Baillie S, Parton R, Coote J.
    Vaccine; 2004 Oct 22; 22(31-32):4270-81. PubMed ID: 15474718
    [Abstract] [Full Text] [Related]

  • 19. Natural history of pertussis antibody in the infant and effect on vaccine response.
    Van Savage J, Decker MD, Edwards KM, Sell SH, Karzon DT.
    J Infect Dis; 1990 Mar 22; 161(3):487-92. PubMed ID: 2313127
    [Abstract] [Full Text] [Related]

  • 20. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
    Kwon HJ, Han SB, Kim BR, Kang KR, Huh DH, Choi GS, Ahn DH, Kang JH.
    BMC Infect Dis; 2017 Apr 04; 17(1):247. PubMed ID: 28376777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.